Advertisement

Oncology

Cancer patients and oncology clinicians continue to grapple with an ongoing national drug shortage that is now affecting 57 percent of hospital pharmacies, according to an American Society of Health-System Pharmacists poll published Aug. 10. 

Advertisement

An AI-powered machine learning tool may allow physicians to better identify origins in enigmatic cancers, according to researchers at the Massachusetts Institute of Technology in Cambridge, Mass., and Dana-Farber Cancer Institute in Boston. 

Detroit-based Barbara Ann Karmanos Cancer Institute, a McLaren Health Care-owned facility, has named Boris Pasche, MD, PhD, as the center's new president and CEO, according to an Aug. 7 news release.

Advertisement